Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...

When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Viking Therapeutics (NASDAQ: VKTX) seems to fit the bill, as it announced fantastic data from trials of its weight loss candidate last February -- and the stock ... is Viking a buy in 2025?

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

BMO Capital analyst Kostas Biliouris has maintained their bullish stance on LEGN stock, giving a Buy rating yesterday.Invest with Confidence: ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

This Biotech Stock Soared 300% Overnight. Why It Can Go Higher. Positive results from clinical trials often give biotechnology companies a boost, but this one was big.